Trial Profile
Patient satisfaction and treatment adherence to ibrutinib for Chronic Lymphocytic Leukemia within the You&I™ Patient Support Program
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Sep 2016
Price :
$35
*
At a glance
- Drugs Ibrutinib (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 12 Sep 2016 New trial record